Although her NWBO job title NWBO may suggest otherwise, I dont believe for a second she is hired to accompany and manage the registry of DCVAX with the Canadian RA. There is zero indication from her CV that suggests she is capable/has any interest of doing so. Besides how many hours per day one could spend doing that? The Canadian RA will follow the FDA in approval. Thus if its the consensus of the board is that the Canadian RA needs a full-time NWBO employee to get approval in CA then thats is very bad news for US approval, if you know what I mean.
I sincerely believe they hired her to manage an investment of a large big pharma in NWBO and or the selling of DCVAX royalties. Or perhaps even the acquisition of NWBO altogether. Then the Q remains why the job title program director? Well given the stock price sensitivity of her real job, they could hardly call it "manager of investment strategist" or "head sales DCVAX royalties" or something like that.
Market Data 
Markets 
AI
